SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891020-04-000553
Filing Date
2004-09-20
Accepted
2004-09-20 14:43:02
Documents
4
Period of Report
2004-09-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v01934e8vk.htm 8-K 11952
2 EXHIBIT 10.1 v01934exv10w1.htm EX-10.1 23694
3 EXHIBIT 99.1 v01934exv99w1.htm EX-99.1 4947
4 GRAPHIC v01934v0193400.gif GRAPHIC 4146
  Complete submission text file 0000891020-04-000553.txt   46858
Mailing Address 22026 20TH AVENUE SE, SUITE 102 BOTHELL WA 98021
Business Address 22026 2OTH AVE SE STE 102 BOTHELL WA 98021 2064879500
SONUS PHARMACEUTICALS INC (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21243 | Film No.: 041037364
SIC: 2835 In Vitro & In Vivo Diagnostic Substances